HomeZBH • NYSE
Zimmer Biomet Holdings Inc
$107.71
Sep 27, 9:00:29 AM GMT-4 · USD · NYSE · Disclaimer
StockGLeaf logoClimate leaderUS listed securityUS headquartered
Previous close
$107.71
Year range
$102.00 - $133.90
Market cap
21.94B USD
Avg Volume
1.50M
P/E ratio
22.45
Dividend yield
0.89%
Primary exchange
NYSE
CDP Climate Change Score
A
Financials
Income Statement
Revenue
Net income
(USD)Jun 2024Y/Y change
Revenue
1.94B3.87%
Operating expense
986.60M0.37%
Net income
242.80M15.84%
Net profit margin
12.5011.51%
Earnings per share
2.0110.44%
EBITDA
645.30M7.80%
Effective tax rate
19.56%
Total assets
Total liabilities
(USD)Jun 2024Y/Y change
Cash and short-term investments
420.10M31.36%
Total assets
21.52B1.06%
Total liabilities
8.77B-1.63%
Total equity
12.75B
Shares outstanding
203.65M
Price to book
1.73
Return on assets
4.68%
Return on capital
5.38%
Net change in cash
(USD)Jun 2024Y/Y change
Net income
242.80M15.84%
Cash from operations
369.40M6.18%
Cash from investing
-247.00M-1.60%
Cash from financing
-91.90M16.00%
Net change in cash
27.10M360.58%
Free cash flow
147.08M-14.61%
About
Zimmer Biomet Holdings, Inc. is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster. In 2001, Zimmer was spun off from Bristol-Myers Squibb and began trading on the New York Stock Exchange, on August 7, under the ticker symbol “ZMH”. In November 2011, the company acquired ExtraOrtho, Inc. In January 2012, the company acquired Reno, Nevada-based Synvasive Technology, Inc. On June 29, 2015, the company changed the ticker symbol to "ZBH" to reflect its acquisition of Biomet. On January 12, 2017, Zimmer Biomet announced a resolution with the DOJ and the SEC in which it agreed to pay a fine of approximately $30.5 million, an amount which would not affect its 2017 outlook. Wikipedia
Founded
1927
Employees
18,000
Search
Clear search
Close search
Google apps
Main menu